Skip to main content
. 2017 Apr 13;8:139. doi: 10.3389/fneur.2017.00139

Table 2.

Demographic information.

All PD (n = 72) Left-onset PD (n = 27) Right-onset PD (n = 45) Non-PD (n = 48)
Age 67.75 ± 5.86 67.19 ± 5.01 68.09 ± 6.34 68.17 ± 4.97
Education 16.28 ± 2.67 16.33 ± 2.29 16.24 ± 2.89 16.89 ± 2.24
Sex (M:F) 51:21 19:8 32:13 38:10
Disease duration 7.00 ± 4.98 5.37 ± 3.10** 7.98 ± 5.63**
MMSE 28.59 ± 1.33* 28.59 ± 1.34 28.58 ± 1.31 29.26 ± 0.94*
WTAR estimated IQ 109.46 ± 7.34 109.52 ± 6.92 109.40 ± 7.76 109.64 ± 8.41
UPDRS part 3 18.04 ± 10.09* 17.74 ± 8.83 18.28 ± 10.92 2.96 ± 3.57*
LED 585.07 ± 334.34* 539.00 ± 232.69 631.13 ± 435.99 0.85 ± 5.83*,a

UPDRS part 3 is the motor symptom scale of the United PD Rating Scale; LED, Levodopa equivalence score; MMSE, mini-mental state examination; WTAR, Wechsler Test of Adult Reading.

aOne non-PD participant was taking levodopa for restless leg syndrome.

*Indicates significant PD/non-PD difference, p < 0.05.

**Indicates significant L-PD/R-PD difference, p < 0.05.